Scilex Holding Company (SCLX) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Scilex Holding Company faces significant financial challenges due to its failure to file the Quarterly Report on Form 10-Q on time, resulting in ineligibility to use Form S-3 for capital raising. This situation forces the company to rely on longer and potentially more costly capital raising processes, such as Form S-1, which could lead to delays and increased expenses. Moreover, this ineligibility may limit Scilex’s ability to repay debts, pursue strategic opportunities, and maintain liquidity, potentially exerting downward pressure on its share price. The company will be unable to regain Form S-3 eligibility until February 1, 2026, which may have a material adverse effect on its financial operations and market positioning.
The average SCLX stock price target is $14.00, implying 3,081.82% upside potential.
To learn more about Scilex Holding Company’s risk factors, click here.
